The association of body mass index, waist and hip circumference, and waist-hip ratio with Chlamydia pneumoniae IgG antibodies and high-sensitive C-reactive protein at 31 years of age in Northern Finland Birth Cohort 1966

International Journal of Obesity

Volumn 35, Issue 12, 2011, Pages 1470-1478

  Lajunen, T ^a,b   Bloigu, A ^b   Paldanius, M ^b,c   Pouta, A ^b,c   Laitinen, J ^d   Ruokonen, A ^c   Hartikainen, A L ^c   Savolainen, M ^a   Herzig, K H ^a,e   Leinonen, M ^b   Saikku, P ^a   Jarvelin M R ^a,f  

^a UNIVERSITY OF OULU   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

^d FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

body mass index; C reactive protein; Chlamydia pneumoniae; overweight; waist hip ratio

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN G ANTIBODY; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BODY MASS; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; ENZYMATIC ASSAY; FEMALE; FINLAND; HUMAN; IMMUNOFLUORESCENCE TEST; INFLAMMATION; LEUKOCYTE; MALE; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE PRESSURE; SMOKING; SOCIOECONOMICS; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; ANTIBODIES, BACTERIAL; BODY MASS INDEX; C-REACTIVE PROTEIN; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOGLOBULIN G; LIFE STYLE; MALE; OBESITY; QUESTIONNAIRES; RISK ASSESSMENT; SAMPLING STUDIES; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

CHLAMYDOPHILA PNEUMONIAE; HELICOBACTER PYLORI;

EID: 84856409930     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2011.21     Document Type: Article

References (44)

1. WHO. Obesity and overweight. In Fact Sheet No. 311. World Health Organization, 2006.
2. Bessesen DH. Update on obesity. J Clin Endocrinol Metab 2008; 93: 2027-2034. (Pubitemid 351831511)
3. Atkinson RL. Viruses as an etiology of obesity. Mayo Clin Proc 2007; 82: 1192-1198. (Pubitemid 47502877)
4. van Ginneken V, Sitnyakowsky L, Jeffery JE. Infectobesity: viral infections (especially with human adenovirus-36: Ad-36) may be a cause of obesity. Med Hypotheses 2009; 72: 383-388.
5. Ekesbo R, Nilsson PM, Lindholm LH, Persson K, Wadström T. Combined seropositivity for H. pylori and C. pneumoniae is associated with age, obesity and social factors. J Cardiovasc Risk 2000; 7: 191-195. (Pubitemid 30463748)
6. Lajunen T, Vikatmaa P, Bloigu A, Ikonen T, Lepäntalo M, Pussinen PJ et al. Chlamydial LPS and high-sensitivity CRP levels in serum are associated with an elevated body mass index in patients with cardiovascular disease. Innate Immun 2008; 14: 375-382.
7. Karppinen J, Mikkonen P, Kurunlahti M, Tervonen O, Paldanius M, Vasari P et al. Chronic Chlamydia pneumoniae infection increases the risk of occlusion of lumbar segmental arteries of patients with sciatica: a 3-year follow-up study. Spine 2003; 28: E284-E289.
8. Thjodleifsson B, Olafsson I, Gislason D, Gislason T, Jögi R, Janson C. Infections and obesity: a multinational epidemiological study. Scand J Infect Dis 2008; 40: 381-386. (Pubitemid 351566564)
9. Fernández-Real JM, Ferri MJ, Vendrell J, Ricart W. Burden of infection and fat mass in healthy middle-aged men. Obesity (Silver Spring) 2007; 15: 245-252. (Pubitemid 46219805)
10. Marrie TJ, Peeling RW, Reid T, De Carolis E. Chlamydia species as a cause of community-acquired pneumonia in Canada. Eur Respir J 2003; 21: 779-784. (Pubitemid 36592284)
11. Nabipour I, Vahdat K, Jafari SM, Pazoki R, Sanjdideh Z. The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: the Persian Gulf Healthy Heart Study. Cardiovasc Diabetol 2006; 5: 25.
12. Dart AM, Martin JL, Kay S. Association between past infection with Chlamydia pneumoniae and body mass index, low-density lipoprotein particle size and fasting insulin. Int J Obes Relat Metab Disord 2002; 26: 464-468. (Pubitemid 34407258)
13. Saikku P. The epidemiology and significance of Chlamydia pneumoniae. J Infect 1992; 25(Suppl 1): 27-34.
14. Hogan RJ, Mathews SA, Mukhopadhyay S, Summersgill JT, Timms P. Chlamydial persistence: beyond the biphasic paradigm. Infect Immun 2004; 72: 1843-1855. (Pubitemid 38419894)
15. Saikku P. Chlamydia pneumoniae-an update on clinical disease. In: Schachter J, Christiansen G, Clarke IN, Hammerschlag M, Kaltenboeck B, Kuo CC et al. (eds). Proceedings of the Tenth International Symposium on Human Chlamydial Infections; Antalaya, Turkey. Grafmat Basin ve Reklam Sanayi Tic. Ltd, STI Publisher: Istanbul, pp 443-453.
16. Saikku P. Epidemiology of Chlamydia pneumoniae in atherosclerosis. Am Heart J 1999; 138 (Part 2): S500-S503. (Pubitemid 29523243)
17. Leinonen M, Saikku P. Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect Dis 2002; 2: 11-17. (Pubitemid 36109301)
18. Mussa FF, Chai H, Wang X, Yao Q, Lumsden AB, Chen C. Chlamydia pneumoniae and vascular disease: an update. J Vasc Surg 2006; 43: 1301-1307. (Pubitemid 43825695)
19. Bouwman JJ, Visseren FL, Bouter KP, Diepersloot RJ. Infectioninduced inflammatory response of adipocytes in vitro. Int J Obes (Lond) 2008; 32: 892-901. (Pubitemid 351986227)
20. Shi Y, Liu Y, Murdin A, Raudonikiene-Mancevski A, Ayach BB, Yu Z et al. Chlamydophila pneumoniae inhibits differentiation of progenitor adipose cells and impairs insulin signaling. J Infect Dis 2008; 197: 439-448. (Pubitemid 351263427)
21. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972-978. (Pubitemid 29177345)
22. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-1565. (Pubitemid 35315836)
23. Cancello R, Clément K. Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG 2006; 113: 1141-1147. (Pubitemid 44401207)
24. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000; 148: 209-214. (Pubitemid 30064452)
25. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-126.
26. Ritchie SA, Connell JM. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 2007; 17: 319-326. (Pubitemid 46551691)
27. Kaftan AH, Kaftan O. Coronary artery disease and infection with chlamydia pneumonia. Jpn Heart J 2000; 41: 165-172.
28. Koziolek M, Krzyzanowska-Swiniarska B, Maczynska I, Miazgowski T, Giedrys-Kalemba S. The association between past Chlamydia pneumoniae infection and markers of chronic inflammation in obese women. Eur J Clin Microbiol Infect Dis 2008; 27: 415-421.
29. Blanc P, Corsi AM, Gabbuti A, Peduzzi C, Meacci F, Olivieri F et al. Chlamydia pneumoniae seropositivity and cardiovascular risk factors: The InCHIANTI Study. J Am Geriatr Soc 2004; 52: 1626-1631. (Pubitemid 41709914)
30. Stanger OH, Semmelrock HJ, Rehak P, Tiran B, Meinitzer A, Rigler B et al. Hyperhomocyst(e)inemia and Chlamydia pneumoniae IgG seropositivity in patients with coronary artery disease. Atherosclerosis 2002; 162: 157-162. (Pubitemid 34327353)
31. Koh WP, Taylor MB, Hughes K, Chew SK, Fong CW, Phoon MC et al. Seroprevalence of IgG antibodies against Chlamydia pneumoniae in Chinese, Malays and Asian Indians in Singapore. Int J Epidemiol 2002; 31: 1001-1007. (Pubitemid 35446875)
32. Falck G, Gnarpe J, Hansson LO, Svärdsudd K, Gnarpe H. Comparison of individuals with and without specific IgA antibodies to Chlamydia pneumoniae: respiratory morbidity and the metabolic syndrome. Chest 2002; 122: 1587-1593. (Pubitemid 35366068)
33. Karinen L, Leinonen M, Bloigu A, Paldanius M, Koskela P, Saikku P et al. Maternal serum Chlamydia pneumoniae antibodies and CRP levels in women with preeclampsia and gestational hypertension. Hypertens Pregnancy 2008; 27: 143-158. (Pubitemid 351892679)
34. Roivainen M, Viik-Kajander M, Palosuo T, Toivanen P, Leinonen M, Saikku P et al. Infections, inflammation, and the risk of coronary heart disease. Circulation 2000; 101: 252-257. (Pubitemid 30054151)
35. Rantakallio P. Groups at risk in low birth weight infants and perinatal mortality. Acta Paediatr Scand 1969; 58 (S193): 5-71.
36. Järvelin MR, Sovio U, King V, Lauren L, Xu B, McCarthy MI et al. Early life factors and blood pressure at age 31 years in the 1966. northern Finland birth cohort. Hypertension 2004; 44: 838-846. (Pubitemid 39577409)
37. Sugiuchi H, Uji Y, Okabe H, Irie T, Uekama K, Kayahara N et al. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. Clin Chem 1995; 41: 717-723.
38. Wieland H, Seidel D. A simple specific method for precipitation of low density lipoproteins. J Lipid Res 1983; 24: 904-909. (Pubitemid 13015571)
39. Wang S. The microimmunofluorescence test for Chlamydia pneumoniae infection: technique and interpretation. J Infect Dis 2000; 181(Suppl 3): S421-S425. (Pubitemid 30416109)
40. Kalayoglu MV, Byrne GI. A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect Immun 1998; 66: 5067-5072. (Pubitemid 29044592)
41. Kalayoglu MV, Byrne GI. Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis 1998; 177: 725-729. (Pubitemid 28099889)
42. Cocchiaro JL, Kumar Y, Fischer ER, Hackstadt T, Valdivia RH. Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole. Proc Natl Acad Sci USA 2008; 105: 9379-9384.
43. Hyvärinen K, Tuomainen AM, Laitinen K, Bykov IL, Törmäkangas L, Jauhiainen M et al. Chronic Chlamydia pneumoniae infection induces liver steatosis in APOE-deficient mive. Abstracts of the 76th Congress of the European Atherosclerosis Society, June 10-13, 2007, Helsinki, Finland. Atheroscler Suppl 2007; 8: 23.
44. Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001; 33: 492-503.